journal article·2014-01

A review of ligand tethered surface engineered carbon nanotubes

Neelesh Kumar Mehra, Vijay Mishra, N.K. Jain

Biomaterials· Volume 35· Issue 4
Publisher page

Abstract

Carbon nanotubes (CNTs) have emerged as fascinating materials, exhibiting promising potential in receptor based targeting owing to their unique physicochemical properties (cell membrane penetration, high surface area and drug payload, biocompatibility, easy surface modification, photoluminescence property, and non-immunogenicity etc). The hydrophilicity, a major constrain associated with the first generation of CNTs i.e. pristine CNTs, could be overcome using functionalization techniques. In the last two decades variety of functionalized CNTs (f-CNTs) i.e. oxidized, amidated, acylated, surfactant and biopolymer-assisted, and biomolecules modified have been developed and utilized as effective, safe, nano sized, and smart systems to deliver a wide range of bioactives in the biological system. The purpose of this review is to examine the various aspects of conjugation and associated conjugation chemistry of various targeting ligands to CNTs for their respective biomedical applications. The various biomolecules have been easily tethered to CNTs surfaces including proteins and amino acid, enzymes, nucleic acid (DNA and siRNA), aptamers, vitamins, monoclonal antibodies, peptides (NGR, RGD and Aniopep-2) and so on, for targeting purposes.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Carbon Nanotubes in Composites · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Functionalized carbon nanotubes for potential medicinal applications10.1016/j.drudis.2010.04.005 ↗
2. http://www.prweb.com/releases/nanotechnology_nanotubes/nanomaterials_nanofilms/prweb9120599.htm [accessed 14.04.13].
3. Nanotechnology-based detection and targeted therapy in cancer: nano-bio paradigms and applications10.3390/cancers3032888 ↗
4. Receptor based therapeutic targeting10.4155/tde.13.6 ↗
5. Targeted drug delivery to macrophages10.1517/17425247.2013.751370 ↗
6. Challenges in the use of carbon nanotubes for biomedical application10.1615/CritRevTherDrugCarrierSyst.v25.i2.20 ↗
7. Carbon nanotubes and their toxicity10.1080/17435390701639688 ↗
8. Role of nanotechnology in targeted drug delivery and imaging: a concise review10.1016/j.nano.2005.06.004 ↗
9. Hyperbranched dendritic nano-carriers for topical delivery of dithranol10.3109/1061186X.2013.771778 ↗
10. Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly (propylene imine) dendrimers10.1016/j.ejps.2012.12.027 ↗
11. A review of glycosylated carriers for drug delivery10.1016/j.biomaterials.2012.02.033 ↗
12. Influence of different generations of poly (propylene imine) dendrimers on human erythrocytes
13. Surface-engineered dendrimers: a solution for toxicity issues10.1163/156856208X386246 ↗
14. Topical delivery of enoxaparin using nanostructured lipid carrier10.3109/02652048.2013.778908 ↗
15. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes10.3109/1061186X.2013.813028 ↗
16. Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes10.3109/1061186X.2012.729213 ↗
17. Folic acid conjugated carbon nanotubes for gemcitabine HCL delivery10.3109/1061186X.2013.778264 ↗
18. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-210.1016/j.biomaterials.2012.01.025 ↗
19. Tissue histology and physiology following intravenous administration of different types functionalized multiwalled carbon nanotubes10.2217/17435889.3.2.149 ↗
20. Translocation mechanisms of chemically functionalized carbon nanotubes across plasma membranes10.1016/j.biomaterials.2012.01.024 ↗
21. Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors10.1016/j.biomaterials.2011.11.004 ↗
22. Macrophages targeting of amphotericin B through mannosylated multi walled carbon nanotubes10.3109/1061186X.2012.697168 ↗
23. Pulmonary toxicity of carbon nanotubes: a systematic report10.1016/j.nano.2010.06.008 ↗
24. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes10.1016/j.biomaterials.2009.07.025 ↗
25. Functionalization of single-walled carbon nanotubes10.1002/1521-3773(20020603)41:11<1853::AID-ANIE1853>3.0.CO;2-N ↗
26. A review of current nanoparticles and targeting moieties for the delivery of cancer therapeutics10.1016/j.ejps.2012.12.006 ↗
27. Helical microtubules of graphitic carbon10.1038/354056a0 ↗
28. Bacon R. Filamentary graphite and method for producing the same. US Patent. 2957756 1960; Issued October 25.
29. Growth, structure and properties of graphite whiskers10.1063/1.1735559 ↗
30. Structure ugleroda, obrazujucegosja pri termiceskom ra-zlozenii okisi ugleroda na zeleznom kontakte
31. Filamentous growth of carbon through benzene decomposition10.1016/0022-0248(76)90115-9 ↗
32. Izvestiya Akademii Nauk SSSR · 1982 · 3 · 12
33. Tennent · 1987
34. Dresselhaus · 1995 · 117 · 129
35. Structure of carbon fibres found on carbon arc anodes10.1016/S0008-6223(99)00199-2 ↗
36. Single-shell carbon nanotubes of 1-nm diameter10.1038/363603a0 ↗
37. Cobalt-catalysed growth of carbon nanotubes with single-atomic layer walls10.1038/363605a0 ↗
38. Who should be given credit for the discovery of carbon nanotubes10.1016/j.carbon.2006.03.019 ↗
39. Monthioux · 2007 · 43
40. Folate and iron difunctionalized multiwall carbon nanotubes as dual-targeted drug nanocarrier to cancer cells10.1016/j.carbon.2011.01.003 ↗
41. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics10.1038/nnano.2009.241 ↗
42. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing10.1021/ja053962k ↗
43. Carbon nanotubes as intracellular protein transporters: generality and biological functionality10.1021/ja050062v ↗
44. Nanotube molecular transporters: internalization of carbon nanotubes-protein conjugates into mammalian cells10.1021/ja0486059 ↗
45. Carbon nanotubes as intracellular transporters for protein and DNA: an investigation of the uptake mechanism and pathway10.1002/anie.200503389 ↗
46. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction10.1073/pnas.0502680102 ↗
47. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotubes radiotracers10.1073/pnas.0509009103 ↗
48. Double functionalization of carbon nanotubes for multimodal drug delivery10.1039/b516309a ↗
49. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes10.1002/anie.200501613 ↗
50. Carbon nano-tubes protect DNA strands during cellular delivery10.1021/nn800325a ↗
51. Preparation of carbon nanotubes bio-conjugates for biomedical applications10.1038/nprot.2009.146 ↗
52. Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics10.1039/B712350G ↗
53. Drug delivery with carbon nanotubes for in vivo cancer treatment10.1158/0008-5472.CAN-08-1468 ↗
54. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy10.1073/pnas.0707654105 ↗
55. A new family of folate-decorated and carbon nanotubes-mediated drug delivery system: synthesis and drug delivery response10.1016/j.addr.2011.04.001 ↗
56. Carbon nanotubes exploration in cancer cell lines10.1016/j.drudis.2012.05.003 ↗
57. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes10.1016/j.colsurfb.2011.08.001 ↗
58. Can carbon nanotubes-liposomes conjugates address the issues associated with carbon nanotubes in drug delivery10.4155/fmc.13.36 ↗
59. Advancement in carbon nanotubes: basics, biomedical applications and toxicity10.1111/j.2042-7158.2010.01167.x ↗
60. Physicochemical properties affecting cellular uptake of carbon nanotubes10.2217/nnm.09.95 ↗
61. Characterization of bundled and individual triple-walled carbon nanotubes by resonant Raman spectroscopy10.1021/nn3055708 ↗
62. Double-walled carbon nanotubes: challenges and opportunities10.1039/C0NR00620C ↗
63. Properties and application of double-walled carbon nanotubes sorted by outer-wall electronic type10.1021/nn103263b ↗
64. http://en.wikipedia.org/wiki/Carbon_nanotube [accessed 14.04.13].
65. Carbohydrate-conjugated multi walled carbon nanotubes: development and characterization10.1016/j.nano.2009.03.001 ↗
66. Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system10.1016/j.jcis.2011.09.013 ↗
67. Current progress on the chemical modification of carbon nanotubes10.1021/cr100018g ↗
68. Chemically induced, thermally controlled peel-off of the external walls of double-walled carbon nanotubes10.1002/smll.201001154 ↗
69. Chemical oxidation of multi walled carbon nanotubes10.1016/j.carbon.2008.02.012 ↗
70. Ligand-targeted therapeutics in anticancer therapy10.1038/nrc903 ↗
71. Ligand based dendritic systems for tumor targeting10.1016/j.ijpharm.2007.09.024 ↗
72. Tumor targeting with antibody-functionalized radiolabeled carbon nanotubes10.2967/jnumed.106.039131 ↗
73. Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities10.1021/nn301869z ↗
74. Engineering of targeted nano-particles for cancer therapy using internalizing aptamers isolated by cell-uptake selection10.1021/nn204165v ↗
75. Apatmer-modified nanodrug delivery systems10.1021/nn2037384 ↗
76. Covalent functionalization of single-walled carbon nanotubes with adenosine monophosphate: towards the synthesis of SWCNT-aptamer hybrids10.1016/j.msec.2011.05.001 ↗
77. In-vitro selection of RNA molecules that bind specific ligands10.1038/346818a0 ↗
78. Aptamers evolved from live cells as effective molecular probes for cancer study10.1073/pnas.0602615103 ↗
79. Single-walled carbon nanotubes biosensors using aptamers as molecular recognition elements10.1021/ja053094r ↗
80. In vivo selection of tumor-targeting RNA motifs10.1038/nchembio.277 ↗
81. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes10.1016/j.ejpb.2010.12.005 ↗
82. Single-walled carbon nanotubes chemiresistor aptasensors for small molecules: picomolar level detection of adenosine triphosphate10.1039/c0cc04733c ↗
83. A post-labeling strategy based on dye-induced peeling of the aptamer off single-walled carbon nanotubes for electrochemical aptasensing10.1039/c0cc05188h ↗
84. New strategy for label-free and time-resolved luminescent assay of protein: conjugate Eu3+ complex and aptamer-wrapped carbon nanotubes10.1021/ac103087z ↗
85. Aptamer sandwich-based carbon nanotubes sensors for single-carbon atomic resolution detection of non-polar small molecular species10.1039/C0LC00259C ↗
86. Label-free protein biosensor based on aptamer-modified carbon nanotube field-effect transistors10.1021/ac060830g ↗
87. Immediate detection of living bacteria at ultralow concentrations using carbon nanotubes based potentiometric aptasensor10.1002/anie.200902090 ↗
88. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery10.1021/nn700040t ↗
89. Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubes10.2147/IJN.S24167 ↗
90. Development of NGR peptide-based agents for tumor imaging
91. NGR peptide ligands for targeting CD13/APN identified through peptide array screening resemble fibronectin sequences10.1021/co300055s ↗
92. Single-walled carbon nanotubes mediated neovasculature targeted antitumor drug delivery system10.18433/J3H02C ↗
93. Surface modification of carbon nanotubes with dendrimer or hyperbranched polymers10.1039/C0PY00356E ↗
94. Antitumor immunologically modified carbon nanotubes for photothermal therapy10.1016/j.biomaterials.2011.12.029 ↗
95. Modulated release of dexamethasone from chitosan-carbon nanotube films10.1016/j.sna.2009.07.021 ↗
96. Carbon nanotubes biofibers10.1002/adma.200601986 ↗
97. Carbon nanotubes biofibre formation in a polymer free coagulation bath10.1002/adfm.200700822 ↗
98. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy10.1081/CNV-100103136 ↗
99. The use of gene-specific IgY antibodies for drug target discovery10.1016/S1359-6446(03)02655-2 ↗
100. Anti-HER2IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells10.1186/1471-2407-9-351 ↗